Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017, Article ID 7931982, 8 pages
https://doi.org/10.1155/2017/7931982
Research Article

Potential Usefulness of Streptococcus pneumoniae Extracellular Membrane Vesicles as Antibacterial Vaccines

1Division of Bioconvergence Analysis, Korea Basic Science Institute, Daejeon, Republic of Korea
2Tunneling Nanotube Research Center, Division of Life Science, Korea University, Seoul 02841, Republic of Korea
3Department of Bio-Analytical Science, University of Science and Technology, Daejeon, Republic of Korea
4Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea
5Department of Functional Genomics, University of Science and Technology, Daejeon, Republic of Korea

Correspondence should be addressed to Seung Il Kim; rk.er.isbk@isk and Gun-Hwa Kim; rk.er.isbk@hgkeneg

Received 30 September 2016; Revised 24 November 2016; Accepted 21 December 2016; Published 22 January 2017

Academic Editor: Giuseppe A. Sautto

Copyright © 2017 Chi-Won Choi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Hirst, H. Yesilkaya, E. Clitheroe et al., “Sensitivities of human monocytes and epithelial cells to pneumolysin are different,” Infection and Immunity, vol. 70, no. 2, pp. 1017–1022, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. S. J. Kelly, K. B. Taylor, S. Li, and M. J. Jedrzejas, “Kinetic properties of Streptococcus pneumoniae hyaluronate lyase,” Glycobiology, vol. 11, no. 4, pp. 297–304, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. T. J. Mitchell, “Virulence factors and the pathogenesis of disease caused by Streptococcus pneumoniae,” Research in Microbiology, vol. 151, no. 6, pp. 413–419, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. M. van der Linden, A. Al-Lahham, W. Nicklas, and R. R. Reinert, “Molecular characterization of pneumococcal isolates from pets and laboratory animals,” PLoS ONE, vol. 4, no. 12, Article ID e8286, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Oligbu, Y. Hsia, L. Folgori, S. Collins, and S. Ladhani, “Pneumococcal conjugate vaccine failure in children: a systematic review of the literature,” Vaccine, vol. 34, no. 50, pp. 6126–6132, 2016. View at Publisher · View at Google Scholar
  6. A. Kulp and M. J. Kuehn, “Biological functions and biogenesis of secreted bacterial outer membrane vesicles,” Annual Review of Microbiology, vol. 64, pp. 163–184, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. C.-W. Choi, E. C. Park, S. H. Yun et al., “Proteomic characterization of the outer membrane vesicle of Pseudomonas putida KT2440,” Journal of Proteome Research, vol. 13, no. 10, pp. 4298–4309, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. E. N. T. Meeusen, J. Walker, A. Peters, P.-P. Pastoret, and G. Jungersen, “Current status of veterinary vaccines,” Clinical Microbiology Reviews, vol. 20, no. 3, pp. 489–510, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. G.-H. Kim, C. W. Choi, E. C. Park, S.-Y. Lee, and S. I. Kim, “Isolation and proteomic characterization of bacterial extracellular membrane vesicles,” Current Protein and Peptide Science, vol. 15, no. 7, pp. 719–731, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Bjune, E. A. Hoiby, J. K. Gronnesby et al., “Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway,” The Lancet, vol. 338, no. 8775, pp. 1093–1096, 1991. View at Publisher · View at Google Scholar · View at Scopus
  11. D. R. Martin, S. J. Walker, M. G. Baker, and D. R. Lennon, “New Zealand epidemic of meningococcal disease identified by a strain with phenotype B:4:P1.4,” Journal of Infectious Diseases, vol. 177, no. 2, pp. 497–500, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. G. V. Sierra, H. C. Campa, N. M. Varcacel et al., “Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba,” NIPH Annals, vol. 14, no. 2, pp. 195–210, 1991. View at Google Scholar
  13. J. Boslego, J. Garcia, C. Cruz et al., “Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile,” Vaccine, vol. 13, no. 9, pp. 821–829, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. C.-W. Choi, Y. G. Lee, S.-O. Kwon et al., “Analysis of Streptococcus pneumoniae secreted antigens by immuno-proteomic approach,” Diagnostic Microbiology and Infectious Disease, vol. 72, no. 4, pp. 318–327, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Olaya-Abril, R. Prados-Rosales, M. J. McConnell et al., “Characterization of protective extracellular membrane-derived vesicles produced by Streptococcus pneumoniae,” Journal of Proteomics, vol. 106, pp. 46–60, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. E.-Y. Lee, D.-Y. Choi, D.-K. Kim et al., “Gram-positive bacteria produce membrane vesicles: proteomics-based characterization of Staphylococcus aureus-derived membrane vesicles,” Proteomics, vol. 9, no. 24, pp. 5425–5436, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Rivera, R. J. B. Cordero, A. S. Nakouzi, S. Frases, A. Nicola, and A. Casadevall, “Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 44, pp. 19002–19007, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Jiang, Q. Kong, K. L. Roland, and R. Curtiss, “Membrane vesicles of Clostridium perfringens type A strains induce innate and adaptive immunity,” International Journal of Medical Microbiology, vol. 304, no. 3-4, pp. 431–443, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. A. M. Mitchell and T. J. Mitchell, “Streptococcus pneumoniae: virulence factors and variation,” Clinical Microbiology and Infection, vol. 16, no. 5, pp. 411–418, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. B. van de Waterbeemd, M. Streefland, P. van der Ley et al., “Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process,” Vaccine, vol. 28, no. 30, pp. 4810–4816, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. T. N. Ellis and M. J. Kuehn, “Virulence and immunomodulatory roles of bacterial outer membrane vesicles,” Microbiology and Molecular Biology Reviews, vol. 74, no. 1, pp. 81–94, 2010. View at Publisher · View at Google Scholar · View at Scopus